Online citations, reference lists, and bibliographies.
← Back to Search

Alcohol And Liver Disease In Europe--Simple Measures Have The Potential To Prevent Tens Of Thousands Of Premature Deaths.

N. Sheron
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In the World Health Organisation European Region, more than 2,370,000 years of life are lost from liver disease before the age of 50; more than lung cancer, trachea, bronchus, oesophageal, stomach, colon, rectum and pancreatic cancer combined. Between 60-80% of these deaths are alcohol related, a disease for which no pharmaceutical therapy has yet been shown to improve long-term survival. The toxicity of alcohol is dose related at an individual level, and is dose related at a population level; overall liver mortality is largely determined by population alcohol consumption. Trends in alcohol consumption correlate closely with trends in overall liver mortality, with 3-5-fold decreases or increases in liver mortality in different European countries over the last few decades. The evidence base for alcohol control measures aimed at reducing population alcohol consumption has been subjected to rigorous evaluation; most recently by the Organisation for Economic Co-Operation and Development (OECD). Effective alcohol policy measures reduce alcohol mortality, including mortality from liver disease. The most effective and cost effective measures have been summarised by the OECD and the World Health Organisation: regular incremental above inflation tax increases, a minimum price for alcohol, effective protection of children from alcohol marketing and low level interventions from clinicians. Simple, cheap and effective changes to alcohol policy by European Institutions and member states have the potential to dramatically reduce liver mortality in Europe.
This paper references
Calling time. The Nation's drinking as a major health issue
N. Sheron (2004)
10.1016/S0140-6736(09)60746-7
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
J. Rehm (2009)
10.1016/j.ypmed.2012.06.006
Health impacts of increasing alcohol prices in the European Union: a dynamic projection.
S. Lhachimi (2012)
10.1136/bmjopen-2014-007516
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
D. Harman (2015)
The reliability of death certification of cirrhosis.
G. Duffy (1971)
The Pareto Effect ( 80 : 20 rule ) in Consumption of Beer , Wine and Spirits : A Preliminary Discussion
C. Habel (2003)
10.3399/bjgp13X673711
Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS).
N. Sheron (2013)
10.1093/med/9780199204854.003.260702
Brief interventions against excessive alcohol consumption
Nick Heather (2010)
10.1093/acprof:oso/9780199551149.001.0001
Alcohol: No Ordinary Commodity: Research and Public Policy
T. Babor (2010)
10.1016/S0167-6296(00)00054-0
The effect of tobacco advertising bans on tobacco consumption.
H. Saffer (2000)
10.1111/add.12178
Misleading UK alcohol industry criticism of Canadian research on minimum pricing.
T. Stockwell (2013)
10.1111/J.1360-0443.2004.00499.X
Brief interventions for hazardous drinkers delivered in primary care are equally effective in men and women.
J. Ballesteros (2004)
10.1016/S0140-6736(12)61689-4
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray (2013)
Alcohol Policy And The Public Good
Tom Fleischer (2016)
10.1371/journal.pone.0033317
DYNAMO-HIA–A Dynamic Modeling Tool for Generic Health Impact Assessments
S. Lhachimi (2012)
[Alcohol advertising and alcohol consumption among youngsters: review of the international literature].
I. Pinsky (2008)
The Independent Review of the Effects of Alcohol Pricing and Promotion
Richard Parker (2008)
10.1016/S0140-6736(10)60058-X
Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model
R. Purshouse (2010)
10.1177/145507259701400401
KemikaliegenerationenCollinMatthew: Altered State. The Story of Ecstasy Culture and Acid House. Serpent's Tail, London & New York1997. 314s.
K. Stenius (1997)
10.1080/09595230600944487
Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.
D. Chisholm (2006)
10.1016/J.DRUGALCDEP.2009.11.007
Corrigendum to “Change over time in alcohol consumption in control groups in brief intervention studies: Systematic review and meta-regression study” [Drug Alcohol Depend. 100 (2009) 107–114]
R Jenkins (2010)
10.1111/j.1360-0443.2009.02521.x
Alcohol-related cirrhosis--early abstinence is a key factor in prognosis, even in the most severe cases.
C. Verrill (2009)
10.7861/clinmedicine.14-4-396
Impact of minimum price per unit of alcohol on patients with liver disease in the UK.
N. Sheron (2014)
The Pareto Effect (80:20 rule) in consumption of liquor: A preliminary discussion
C. Habel (2003)
The 2007 ESPAD report : substance use among students in 35 European countries
B. Hibell (2009)
10.1177/1757913912443487
Universal alcohol misuse prevention programmes for children and adolescents: Cochrane systematic reviews
D. Foxcroft (2012)
10.1111/j.1467-8489.2007.00365.x
The Demand for Alcohol: A Meta-Analysis of Elasticities
Craig A. Gallet (2007)
10.1590/S1516-44462008005000015
O impacto da publicidade de bebidas alcoólicas sobre o consumo entre jovens: revisão da literatura internacional
I. Pinsky (2008)
10.15288/JSA.2004.65.782
Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
D. Chisholm (2004)
10.1111/J.1467-8489.1963.TB00319.X
A PROPOSAL FOR AN INTERNATIONAL IMPORT ASSURANCE ARRANGEMENT
E. S. Hoffman (1963)
10.1136/tobaccocontrol-2014-052022
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
F. Chaloupka (2014)
Alcohol and inequities. Guidance for addressing inequitiesin alcohol-related harm.
Belinda Loring (2014)
10.1111/j.1465-3362.2009.00071.x
The effectiveness of brief alcohol interventions in primary care settings: a systematic review.
E. Kaner (2009)
10.15288/JSA.2004.65.191
Engaging general practitioners in the management of hazardous and harmful alcohol consumption: results of a meta-analysis.
P. Anderson (2004)
10.1016/S0140-6736(14)61838-9
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
R. Williams (2014)
10.1080/09595238380000231
ALCOHOL CONTROL POLICIES
A. Wodak (1983)
10.1016/j.drugalcdep.2008.09.016
Change over time in alcohol consumption in control groups in brief intervention studies: systematic review and meta-regression study.
Richard J Jenkins (2009)
10.1111/j.1360-0443.2008.02438.x
Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies.
A. Wagenaar (2009)
10.1016/S0140-6736(12)60244-X
Projections of alcohol-related deaths in England and Wales—tragic toll or potential prize?
N. Sheron (2012)
10.1016/S0140-6736(09)60744-3
Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol
Peter Anderson (2009)
10.2105/AJPH.2009.186007
Effects of alcohol tax and price policies on morbidity and mortality: a systematic review.
A. Wagenaar (2010)
Alcohol in Europe: a public health perspective
P. Anderson (2006)
10.1111/j.1465-3362.2009.00055.x
Warnings on alcohol containers and advertisements: international experience and evidence on effects.
C. Wilkinson (2009)
Alcohol Control Policies in Public Health Perspective
K. Bruun (1975)
10.1111/j.1465-3362.2009.00153.x
Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.
J. Rehm (2010)
10.1111/add.12139
The relationship between minimum alcohol prices, outlet densities and alcohol-attributable deaths in British Columbia, 2002-09.
J. Zhao (2013)
10.1111/add.12855
Are the Public Health Responsibility Deal alcohol pledges likely to improve public health? An evidence synthesis.
C. Knai (2015)
10.1186/1471-2458-9-51
The effect of alcohol advertising, marketing and portrayal on drinking behaviour in young people: systematic review of prospective cohort studies
L. Smith (2009)
WHO. WHO mortality database: raw data files
GJ Duffy (2015)
10.1093/OXFORDJOURNALS.AJE.A113256
SERUM-γ-GLUTAMYLTRANSFERASE IN SCREENING AND CONTINUOUS CONTROL OF HEAVY DRINKING IN MIDDLE-AGED MEN
H. Kristenson (1981)
10.1016/J.JHEP.2013.10.017
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.
J. Morling (2014)
Office for National Statistics; 2013 Oct 28
T Stockwell (2012)
10.1111/j.1360-0443.2009.02708.x
Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia.
L. Cobiac (2009)
Tackling harmful alcohol use: economics and public health policy.
F. Sassi (2015)
Serum-gamma-glutamyltransferase in screening and continuous control of heavy drinking in middle-aged men.
H. Kristenson (1981)
10.1046/J.1360-0443.2002.00262.X
Alcohol-related human losses in Russia in the 1980s and 1990s.
A. Nemtsov (2002)
10.1002/14651858.CD010704.pub2
Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents.
N. Siegfried (2014)
10.1057/hsq.2011.7
Social inequalities in alcohol‐related adult mortality by National Statistics Socio‐economic Classification, England and Wales, 2001–03
V. Siegler (2011)
Assessment of young people’s exposure to alcohol marketing in audiovisual and online media.
E. Winpenny (2012)
10.1186/1741-7015-6-36
The cost-effectiveness of increasing alcohol taxes: a modelling study
M. van den Berg (2008)
Alcohol and inequities - Guidance for addressing inequities in alcohol-related harm
Regional office for Europe (2014)
10.1186/s12916-014-0145-y
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
A. Mokdad (2014)
10.1016/j.healthplace.2011.11.003
A systematic review of the influence on alcohol use of community level availability and marketing of alcohol.
A. Bryden (2012)
10.3386/w18180
Behavioral Economics and the Demand for Alcohol: Results from the Nlsy97
H. Saffer (2012)
10.1111/j.1360-0443.2008.02493.x
Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease.
J. Hatton (2009)
10.1093/alcalc/agn115
Impact of alcohol advertising and media exposure on adolescent alcohol use: a systematic review of longitudinal studies.
P. Anderson (2009)
10.1136/bmj.e8501
Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial
E. Kaner (2013)
The 2011 ESPAD report: substance use amongst students
B Hibell (2011)
Altered State: The story of ecstasy culture and acid
M. Collin (1997)
Alcohol Marketing and Young People's Drinking: A Review of the Research
A. Team (2010)



This paper is referenced by
10.5604/01.3001.0011.7379
Viewpoint: "Alcohol Consumption in Late Adolescence is Associated with an Increased Risk of Severe Liver Disease Later in Life".
A. Tamburello (2018)
10.1016/j.jhep.2018.10.041
Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study.
M. Thursz (2019)
10.1016/j.cgh.2019.07.060
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.
A. Moon (2019)
10.1016/j.jhep.2017.12.015
Managing excessive alcohol consumption at a population level: The earlier the better.
A. Louvet (2018)
10.1159/000456580
Lessons from Epidemiology: The Burden of Liver Disease
I. Rowe (2017)
10.1016/j.jhep.2018.03.018
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.
M. Thursz (2018)
10.1111/imj.13258
Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
K. Williamson (2016)
10.3748/wjg.v26.i22.2916
Nutrition in alcohol-related liver disease: Physiopathology and management
Umair Kamran (2020)
10.1038/s41572-018-0014-7
Alcoholic liver disease
H. Seitz (2018)
10.1055/s-0038-1627457
Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
J. Trebicka (2018)
10.1007/s11605-020-04540-7
Incidence of and Risk Factors for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease: Comparison Between Deceased Donor and Living Donor Liver Transplantation
Hye Gyo Chung (2020)
10.2174/157488711403190718125454
Alcoholic Liver Disease: From Bench to Bedside.
Ludovico Abenavoli (2019)
10.1371/journal.pcbi.1008244
Alcoholic liver disease: A registry view on comorbidities and disease prediction
Dhouha Grissa (2020)
10.5009/gnl11031
Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
F. Stickel (2017)
10.1016/j.bpg.2017.09.003
Alcohol, smoking and the liver disease patient.
H. Hagström (2017)
10.1111/dar.12403
The families and friends of heavy drinkers: Caught in the cross‐fire of policy change?
F. O'May (2017)
10.1016/j.jhep.2018.10.036
Treating alcohol-related liver disease from a public health perspective.
T. Hydes (2019)
10.1371/journal.pone.0162980
The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011
J. Bouttell (2016)
10.2147/JIR.S216125
Investigating the effect of Crocus sativus L. petal hydroalcoholic extract on inflammatory and enzymatic indices resulting from alcohol use in kidney and liver of male rats
Monireh Azizi (2019)
10.1007/s15010-019-01345-y
Epidemiological and etiological variations in hepatocellular carcinoma
E. Sagnelli (2019)
10.1016/S0140-6736(18)31734-3
The Lancet–EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities
M. Manns (2018)
10.1002/hep.30369
Alcohol‐Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study
G. Szabo (2019)
10.1111/jgh.14770
Genetic and lifestyle risk factors for advanced liver disease among men and women
Perttu Sahlman (2019)
10.5604/16652681.1231586
Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A nationwide Analysis.
H. Perazzo (2017)
10.7861/clinmedicine.18-2-s66
Surveillance for hepatocellular cancer.
Anna Roskilly (2018)
10.17265/2328-2150/2018.01.006
Liver Histology after Chronic Use of Alcohol and Exercise Training in Rats
Marina Silva de Lucca (2018)
10.1007/s00018-018-2852-6
Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease
N. Zhao (2018)
Alcoholic liver disease: A review
P. Rekha (2019)
10.1093/alcalc/agz070
Falling Rates of Hospital Admissions for Alcoholic Liver Disease in Northeast Italy: A Retrospective Study on a Large Database.
Diego Caroli (2019)
10.1016/j.cld.2018.09.004
Alcohol Use Disorders in Alcoholic Liver Disease.
J. Mellinger (2019)
10.1007/978-3-319-98890-0_1
Clinical Aspects of Alcoholic Liver Disease
Mads Israelsen (2019)
10.1101/2020.10.16.337592
A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver disease
Lili Niu (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar